Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's Disease: a case study and review of the literature

被引:12
作者
Basu, Sandip [1 ]
Nair, Narendra [1 ]
机构
[1] Bhabha Atom Res Ctr, Radiat Med Ctr, Bombay 400012, Maharashtra, India
关键词
neurofibromatosis; 1; von Recklinghausen's Disease; neurofibrosarcoma; FDG PET;
D O I
10.1007/s11060-006-9161-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background The diagnosis of sarcomatous transformation of plexiform neurofibromas in Neurofibromatosis-1 (NF 1) is a clinical and radiological challenge. Considerable overlap exists in the clinical and the radiological characteristics between the benign enlarging neurofibromas and their counterparts undergoing malignant changes. Surgical biopsy to rule out suspicious malignant transformation is often a problem in deep seated lesions. Methods We, in this paper, explore the clinical utility of FDG-PET in detecting and assessing this life threatening complication of neurofibromas. A case is described with FDG-PET and MRI documentation of such transformation and subsequent histopathological correlation. The case upholds the potential advantages of a FDG-PET over the conventional imaging modalities. A review of the existing literature is also carried out; a total of four published reports on this issue were identified in English literature by searches of Pubmed. Results and conclusion FDG-PET appeared a reliable as well as sensitive noninvasive technique that might minimize unnecessary deep surgical biopsy to rule out malignant transformation in cases of NF-1 with features of enlargement of a preexisting peripheral nerve sheath tumour, pain or neurodeficit.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 18 条
[1]
Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]
GENE FOR VON RECKLINGHAUSEN NEUROFIBROMATOSIS IS IN THE PERICENTROMERIC REGION OF CHROMOSOME-17 [J].
BARKER, D ;
WRIGHT, E ;
NGUYEN, K ;
CANNON, L ;
FAIN, P ;
GOLDGAR, D ;
BISHOP, DT ;
CAREY, J ;
BATY, B ;
KIVLIN, J ;
WILLARD, H ;
WAYE, JS ;
GREIG, G ;
LEINWAND, L ;
NAKAMURA, Y ;
OCONNELL, P ;
LEPPERT, M ;
LALOUEL, JM ;
WHITE, R ;
SKOLNICK, M .
SCIENCE, 1987, 236 (4805) :1100-1102
[3]
ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]
BRENNER W, 2006, EUR J NUCL MED MOL I, V11, P1
[5]
Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours [J].
Cardona, S ;
Schwarzbach, M ;
Hinz, U ;
Dimitrakopoulou-Strauss, A ;
Attigah, N ;
Mechtersheimer, G ;
Lehnert, T .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (06) :536-541
[6]
Retroperitoneal malignant peripheral nerve sheath tumor: Evaluation with serial FDG-PET [J].
Chander, S ;
Westphal, SM ;
Zak, IT ;
Bloom, DA ;
Zingas, AP ;
Joyrich, RN ;
Littrup, PJ ;
Taub, JW ;
Getzen, TM .
CLINICAL NUCLEAR MEDICINE, 2004, 29 (07) :415-418
[7]
COTRAN RS, 1994, ROBBINS PATHOLOGIC B, P1353
[8]
Use of the National Institutes of Health Criteria for diagnosis of neurofibromatosis 1 in children [J].
DeBella, K ;
Szudek, J ;
Friedman, JM .
PEDIATRICS, 2000, 105 (03) :608-614
[9]
IDENTIFICATION AND CHARACTERIZATION OF THE NEUROFIBROMATOSIS TYPE-1 PROTEIN PRODUCT [J].
DECLUE, JE ;
COHEN, BD ;
LOWY, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :9914-9918
[10]
Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 [J].
Ferner, RE ;
Lucas, JD ;
O'Doherty, MJ ;
Hughes, RAC ;
Smith, MA ;
Cronin, BF ;
Bingham, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (03) :353-357